Total Payments
$3,361
2024 Payments
$667.54
Companies
31
Transactions
225
Medicare Patients
14,122
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$3,327 (99.0%)
Education$33.31 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,327 | 222 | 99.0% |
| Education | $33.31 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $748.61 | 55 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $376.85 | 30 | $0 (2024) |
| Abbott Laboratories | $376.14 | 15 | $0 (2023) |
| PFIZER INC. | $324.15 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $206.49 | 28 | $0 (2022) |
| Amgen Inc. | $163.79 | 12 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $138.89 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $114.27 | 6 | $0 (2024) |
| Novo Nordisk Inc | $111.11 | 6 | $0 (2024) |
| Boston Scientific Corporation | $87.03 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $667.54 | 37 | Novartis Pharmaceuticals Corporation ($137.13) |
| 2023 | $758.81 | 57 | PFIZER INC. ($186.35) |
| 2022 | $592.01 | 29 | Abbott Laboratories ($173.79) |
| 2021 | $277.91 | 16 | Novartis Pharmaceuticals Corporation ($67.17) |
| 2020 | $82.72 | 5 | Abbott Laboratories ($39.64) |
| 2019 | $257.99 | 16 | Novartis Pharmaceuticals Corporation ($80.00) |
| 2018 | $235.14 | 16 | Novartis Pharmaceuticals Corporation ($81.82) |
| 2017 | $488.57 | 49 | Janssen Pharmaceuticals, Inc ($150.89) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.53 | General |
| Category: Cardiovascular | ||||||
| 12/06/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.94 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Medical Device | ||||||
| 10/31/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: CDS - BG Mini_RM | ||||||
| 10/22/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Lithoplasty | ||||||
| 10/17/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/15/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/08/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Lithoplasty | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Lithoplasty | ||||||
| 09/09/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Medical Device | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Medical Device | ||||||
| 07/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $34.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: Cardiovascular | ||||||
| 05/10/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Medical Device | ||||||
| 05/07/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: CDS - BG Mini_RM | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,230 | 5,172 | $1.1M | $245,077 |
| 2022 | 41 | 3,762 | 6,045 | $1.0M | $281,856 |
| 2021 | 38 | 3,511 | 5,554 | $936,566 | $296,365 |
| 2020 | 44 | 3,619 | 5,712 | $999,024 | $308,092 |
Total Patients
14,122
Total Services
22,483
Medicare Billing
$1.1M
Procedure Codes
164
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 426 | 590 | $140,550 | $55,535 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 162 | 164 | $119,551 | $23,454 | 19.6% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 29 | 29 | $115,623 | $21,043 | 18.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 214 | 266 | $79,593 | $15,085 | 19.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 343 | 725 | $60,842 | $12,073 | 19.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 240 | 519 | $56,649 | $11,113 | 19.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 53 | 212 | $39,131 | $9,750 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 158 | $26,614 | $8,909 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $20,739 | $8,088 | 39.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 63 | $32,601 | $8,082 | 24.8% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 26 | 33 | $35,962 | $7,407 | 20.6% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 28 | 28 | $30,479 | $6,405 | 21.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 102 | 201 | $36,381 | $5,371 | 14.8% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 44 | 64 | $25,430 | $4,827 | 19.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 116 | 252 | $24,000 | $4,815 | 20.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 72 | $13,406 | $4,274 | 31.9% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 84 | 105 | $21,297 | $3,487 | 16.4% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 42 | 49 | $18,063 | $3,382 | 18.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 18 | 386 | $15,795 | $3,151 | 19.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 16 | 16 | $13,734 | $2,939 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 227 | 283 | $14,543 | $2,894 | 19.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 29 | $10,215 | $2,839 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $8,383 | $2,801 | 33.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 56 | 56 | $14,421 | $2,705 | 18.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 148 | 183 | $15,555 | $2,384 | 15.3% |
About Dr. Ali Kizilbash, M.D
Dr. Ali Kizilbash, M.D is a Internal Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104825090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Kizilbash, M.D has received a total of $3,361 in payments from pharmaceutical and medical device companies, with $667.54 received in 2024. These payments were reported across 225 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,327).
As a Medicare-enrolled provider, Kizilbash has provided services to 14,122 Medicare beneficiaries, totaling 22,483 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Clinical Cardiac Electrophysiology
- Location Irving, TX
- Active Since 07/21/2005
- Last Updated 06/21/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104825090
Products in Payments
- ENTRESTO (Drug) $526.44
- ELIQUIS (Drug) $392.58
- LEQVIO (Drug) $222.17
- VYNDAQEL (Drug) $207.41
- XARELTO (Drug) $206.49
- Corlanor (Drug) $152.58
- LifeVest (Device) $138.89
- MULTAQ (Drug) $114.27
- CAMZYOS (Drug) $96.53
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $88.81
- BodyGuardian (Device) $87.03
- XIENCE SIERRA (Device) $80.19
- Rybelsus (Drug) $75.92
- FFRct (Device) $65.64
- Xience Sierra Coronary Stent System (Device) $62.47
- (CK4) MCOT (Device) $57.52
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $52.69
- INSPIRE (Device) $43.16
- ENROUTE Transcarotid Neuroprotection System (Device) $42.81
- GraftMaster coronary stent system (Device) $40.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irving
Dr. Samata Basani, M.d, M.D
Internal Medicine — Payments: $302,290
Internal Medicine $302,290
Dr. Shiraj Sen, M.d, M.D
Internal Medicine — Payments: $81,865
Internal Medicine $81,865
Branden Snyder, M.d, M.D
Internal Medicine — Payments: $29,735
Internal Medicine $29,735
Ahmed Iqbal, M.d, M.D
Internal Medicine — Payments: $24,674
Internal Medicine $24,674
Nauman Siddiqi, Md, MD
Internal Medicine — Payments: $19,851
Internal Medicine $19,851
Dr. Enid Romanelli, M.d, M.D
Internal Medicine — Payments: $14,115
Internal Medicine $14,115